🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆
Sreepriya Prasannan

Sreepriya Prasannan

Life Science Journalist & Editor

Sreepriya Prasannan is the Founder and Editor of Priya Life Science, Ireland's independent pharma, biotech and MedTech platform. She holds an MSc in Digital Transformation (Life Science) from Griffith College Dublin, with a background in QA, GMP and production operations. Shortlisted for STEM Graduate of the Year at the Business Post Women in STEM Awards 2026 and a Top 14 finalist in the HSE Spark Ignite 2026 innovation programme, she writes on regulatory trends, GMP compliance and careers across the Irish and European life sciences.

222
Articles
7
Topics
1444
Min Published
LinkedIn
Filter: All 222 Industry 101 Regulatory Affairs 42 Pharmaceutical 30 Biotechnology 16 MedTech 16 LinkedIn 12 Clinical Trials 5

All Articles

Page 7 of 19 — 222 articles
MGS Mfg. Group Scales Up European Healthcare Manufacturing with 115,000 Sq Ft Leixlip Hub
Biotechnology
MGS Mfg. Group Scales Up European Healthcare Manufacturing with 115,000 Sq Ft Leixlip Hub
MGS Mfg. Group completes a major 115,000 sq ft expansion of its Leixlip, Ireland facility, boosting ISO Class 7 and 8 cleanroom capacity, advanced automation, and controlled "whiteroom" environments to meet surging European medical device and pharmaceutical demands.
14 Jul 2026 5 min
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Regulatory Affairs
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Irish Health Minister Jennifer Carroll MacNeill positions the €10 billion EU Biotech Act as a key priority for Ireland's Council Presidency, aiming to reverse the decline in clinical trials while balancing pharmaceutical incentives against patient access to affordable therapies.
14 Jul 2026 5 min
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
Regulatory Affairs
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
The latest EFPIA Patients W.A.I.T. Indicator report reveals that Irish patients wait an average of 801 days to access newly approved medicines, prompting calls for an overhaul of the HSE and NCPE reimbursement processes and a dedicated mechanism for rare disease orphan drugs.
14 Jul 2026 5 min
Beyond Google: Why B2B Pharma is Adopting 'Search Everywhere' and Generative Engine Optimization (GEO) in 2026
Industry
Beyond Google: Why B2B Pharma is Adopting 'Search Everywhere' and Generative Engine Optimization (GEO) in 2026
As professional buyers shift from search engines to AI assistants and LinkedIn for vendor research, B2B pharmaceutical and life science companies are pivoting from traditional keyword rankings to "Search Everywhere" and Generative Engine Optimization (GEO).
09 Jul 2026 5 min
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre
Industry
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre
The University of Galway has been chosen to lead the new €64.5 million Research Ireland Rinn Medical Devices Centre as part of a landmark €460 million government investment in seven new national Rinn research centres.
09 Jul 2026 5 min
Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026
Industry
Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026
Chanelle Pharma has confirmed the renewal of its long-standing partnership with the Galway Races Summer Festival for 2026, marking 41 consecutive years of sponsoring the prestigious Leading Trainer Award alongside the Best Turned Out Series.
09 Jul 2026 4 min
The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape
Industry
The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape
Ireland's contract manufacturing exports-colloquially known as "phantom exports"-are surging once again, raising fresh questions about the decoupling of headline economic figures from the domestic life sciences economy.
09 Jul 2026 5 min
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
Pharmaceutical
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
The FDA CBER warning letter issued to Genzyme Ireland’s Waterford site in June 2026 is a watershed moment for Irish biopharma. From 11x repeated filter tests to discarded checklists and unexplained deviation cancellations, we analyze the specific CGMP violations and detail what this compliance failure means for quality management across the sector.
08 Jul 2026 9 min
The Complete LinkedIn Brand-Building Playbook for Pharma and Life Sciences
Pharmaceutical
The Complete LinkedIn Brand-Building Playbook for Pharma and Life Sciences
LinkedIn is the most powerful platform for pharmaceutical and life sciences professionals to build authority and reach target customers. This complete guide covers company page setup, what to post, best times to publish, how to grow connections, and how to turn LinkedIn into a consistent pipeline.
08 Jul 2026 4 min
The Newsletter Advantage: How Pharma Companies Use Email to Reach the Right People Every Time
Pharmaceutical
The Newsletter Advantage: How Pharma Companies Use Email to Reach the Right People Every Time
Newsletters are the most cost-effective marketing tool for pharmaceutical companies. Unlike social media, a newsletter lands directly in the inbox of every person who chose to hear from you. This step-by-step guide explains how to set one up, what to put in it, and how to reach target customers efficiently.
08 Jul 2026 5 min
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
Biotechnology
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
In a deal announced on July 7, 2026, Woodberry Packaging - the Dublin-backed packaging group led by veteran entrepreneur Patrick Doran - has acquired Medica Packaging, the UK's largest independent pharmaceutical carton converter, and F.G. Curtis, a respected name in cosmetics and personal care packaging. The combined group now employs 650 people across the UK and Ireland with revenues exceeding €120 million, marking a significant consolidation moment in the specialist packaging sector.
08 Jul 2026 7 min
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected
Regulatory Affairs
The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected
Jefferies has revised its debut-quarter US sales estimate for Eli Lilly's oral GLP-1 drug Foundayo (orforglipron) down to $71 million - well below the Wall Street consensus of $130 million and sharply below its own prior estimate of $85 million. With weekly prescriptions hovering around 20,000 and Novo Nordisk's oral Wegovy outpacing it on trajectory, the first oral non-peptide GLP-1 for obesity is generating a very different story than the hype suggested.
06 Jul 2026 8 min